Basel Medical Group Ltd (NASDAQ:BMGL) Short Interest Update

Basel Medical Group Ltd (NASDAQ:BMGL) was the recipient of a significant drop in short interest during the month of July. As of July 31st, there was short interest totaling 15,664 shares, a drop of 51.9% from the July 15th total of 32,559 shares. Based on an average trading volume of 7,540 shares, the short-interest ratio is currently 2.1 days. Currently, 1.0% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, August 3rd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of BMGL. Marex Group plc acquired a new stake in shares of Basel Medical Group in the second quarter valued at approximately $25,000. Virtu Financial LLC boosted its position in shares of Basel Medical Group by 108.8% during the third quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock worth $61,000 after buying an additional 17,608 shares during the period. Finally, Citadel Advisors LLC acquired a new position in shares of Basel Medical Group during the third quarter worth approximately $169,000.

Basel Medical Group Stock Up 16.5%

BMGL stock traded up $0.76 during mid-day trading on Friday, reaching $5.38. The company had a trading volume of 37,792 shares, compared to its average volume of 6,113. Basel Medical Group has a one year low of $4.17 and a one year high of $25.80. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.83 and a current ratio of 1.88. The stock’s 50-day simple moving average is $6.40 and its two-hundred day simple moving average is $7.17.

Basel Medical Group (NASDAQ:BMGL) last released its quarterly earnings results on Friday, June 26th. The company reported $0.01 EPS for the quarter. The firm had revenue of $3.21 million for the quarter.

Basel Medical Group Company Profile

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.